Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 25 entries
Sorted by: Best Match Show Resources per page
In vitro differentiation of rat mesenchymal stem cells to hepatocyte lineage.

Iranian journal of basic medical sciences

Sarvandi SS, Joghataei MT, Parivar K, Khosravi M, Sarveazad A, Sanadgol N.
PMID: 25810881
Iran J Basic Med Sci. 2015 Jan;18(1):89-97.

OBJECTIVES: Mesenchyme is a type of undifferentiated loose connective tissue that is derived mostly from mesoderm. Recently, mesenchymal stem cells (MSCs), as adult stem cells (ASCs) able to divide into a variety of different cells, are of utmost importance...

Cite
Sarvandi SS, Joghataei MT, Parivar K, et al. In vitro differentiation of rat mesenchymal stem cells to hepatocyte lineage. Iran J Basic Med Sci. 2015;18(1):89-97
Sarvandi, S. S., Joghataei, M. T., Parivar, K., Khosravi, M., Sarveazad, A., & Sanadgol, N. (2015). In vitro differentiation of rat mesenchymal stem cells to hepatocyte lineage. Iranian journal of basic medical sciences, 18(1), 89-97.
Sarvandi, Samaneh Solati, et al. "In vitro differentiation of rat mesenchymal stem cells to hepatocyte lineage." Iranian journal of basic medical sciences vol. 18,1 (2015): 89-97.
Sarvandi SS, Joghataei MT, Parivar K, Khosravi M, Sarveazad A, Sanadgol N. In vitro differentiation of rat mesenchymal stem cells to hepatocyte lineage. Iran J Basic Med Sci. 2015 Jan;18(1):89-97. PMID: 25810881; PMCID: PMC4366749.
Copy Download .nbib Format: NLM
Effect of palmitic acid and linoleic acid on expression of ICAM-1 and VCAM-1 in human bone marrow endothelial cells (HBMECs).

Archives of medical science : AMS

Sanadgol N, Mostafaie A, Mansouri K, Bahrami G.
PMID: 22661989
Arch Med Sci. 2012 May 09;8(2):192-8. doi: 10.5114/aoms.2012.28544.

INTRODUCTION: The amount and type of fatty acids (FAs) in the diet influence the risk of atherosclerosis. Palmitic acid and linoleic acid exist at high levels in Iranian edible oils. In this study, we investigated the effect of palmitic...

Cite
Sanadgol N, Mostafaie A, Mansouri K, et al. Effect of palmitic acid and linoleic acid on expression of ICAM-1 and VCAM-1 in human bone marrow endothelial cells (HBMECs). Arch Med Sci. 2012;8(2):192-8doi: 10.5114/aoms.2012.28544.
Sanadgol, N., Mostafaie, A., Mansouri, K., & Bahrami, G. (2012). Effect of palmitic acid and linoleic acid on expression of ICAM-1 and VCAM-1 in human bone marrow endothelial cells (HBMECs). Archives of medical science : AMS, 8(2), 192-8. https://doi.org/10.5114/aoms.2012.28544
Sanadgol, Nima, et al. "Effect of palmitic acid and linoleic acid on expression of ICAM-1 and VCAM-1 in human bone marrow endothelial cells (HBMECs)." Archives of medical science : AMS vol. 8,2 (2012): 192-8. doi: https://doi.org/10.5114/aoms.2012.28544
Sanadgol N, Mostafaie A, Mansouri K, Bahrami G. Effect of palmitic acid and linoleic acid on expression of ICAM-1 and VCAM-1 in human bone marrow endothelial cells (HBMECs). Arch Med Sci. 2012 May 09;8(2):192-8. doi: 10.5114/aoms.2012.28544. PMID: 22661989; PMCID: PMC3361029.
Copy Download .nbib Format: NLM
Monitoring of active human herpes virus 6 infection in Iranian patients with different subtypes of multiple sclerosis.

Journal of pathogens

Ramroodi N, Sanadgol N, Ganjali Z, Niazi AA, Sarabandi V, Moghtaderi A.
PMID: 23431459
J Pathog. 2013;2013:194932. doi: 10.1155/2013/194932. Epub 2013 Jan 22.

Background. Recently, it has been suggested that human herpes virus 6 (HHV6) may play a role in the pathogenesis of multiple sclerosis (MS). Our purpose is to determine the incidence of reactivated HHV6 in MS patients. Methods. Viral sequence...

Cite
Ramroodi N, Sanadgol N, Ganjali Z, et al. Monitoring of active human herpes virus 6 infection in Iranian patients with different subtypes of multiple sclerosis. J Pathog. 2013;2013:194932doi: 10.1155/2013/194932.
Ramroodi, N., Sanadgol, N., Ganjali, Z., Niazi, A. A., Sarabandi, V., & Moghtaderi, A. (2013). Monitoring of active human herpes virus 6 infection in Iranian patients with different subtypes of multiple sclerosis. Journal of pathogens, 2013194932. https://doi.org/10.1155/2013/194932
Ramroodi, Nourollah, et al. "Monitoring of active human herpes virus 6 infection in Iranian patients with different subtypes of multiple sclerosis." Journal of pathogens vol. 2013 (2013): 194932. doi: https://doi.org/10.1155/2013/194932
Ramroodi N, Sanadgol N, Ganjali Z, Niazi AA, Sarabandi V, Moghtaderi A. Monitoring of active human herpes virus 6 infection in Iranian patients with different subtypes of multiple sclerosis. J Pathog. 2013;2013:194932. doi: 10.1155/2013/194932. Epub 2013 Jan 22. PMID: 23431459; PMCID: PMC3566604.
Copy Download .nbib Format: NLM
Human herpesvirus-6 and epstein-barr virus infections at different histopathological grades of oral squamous cell carcinomas.

International journal of preventive medicine

Saravani S, Miri-Moghaddam E, Sanadgol N, Kadeh H, Nazeri MR.
PMID: 25400880
Int J Prev Med. 2014 Oct;5(10):1231-8.

BACKGROUND: The aim of this study was to determine the prevalence and viral load of Epstein-Barr virus (EBV) and Human herpesvirus-6 (HHV-6) in different histopathologic grades of oral squamous cell carcinoma (OSCC).METHODS: Forty-five formalin-fixed paraffin-embedded tissue section of OSCC...

Cite
Saravani S, Miri-Moghaddam E, Sanadgol N, et al. Human herpesvirus-6 and epstein-barr virus infections at different histopathological grades of oral squamous cell carcinomas. Int J Prev Med. 2014;5(10):1231-8
Saravani, S., Miri-Moghaddam, E., Sanadgol, N., Kadeh, H., & Nazeri, M. R. (2014). Human herpesvirus-6 and epstein-barr virus infections at different histopathological grades of oral squamous cell carcinomas. International journal of preventive medicine, 5(10), 1231-8.
Saravani, Shirin, et al. "Human herpesvirus-6 and epstein-barr virus infections at different histopathological grades of oral squamous cell carcinomas." International journal of preventive medicine vol. 5,10 (2014): 1231-8.
Saravani S, Miri-Moghaddam E, Sanadgol N, Kadeh H, Nazeri MR. Human herpesvirus-6 and epstein-barr virus infections at different histopathological grades of oral squamous cell carcinomas. Int J Prev Med. 2014 Oct;5(10):1231-8. PMID: 25400880; PMCID: PMC4223941.
Copy Download .nbib Format: NLM
Effect of sertraline on uremic pruritus improvement in ESRD patients.

International journal of nephrology

Shakiba M, Sanadgol H, Azmoude HR, Mashhadi MA, Sharifi H.
PMID: 22973512
Int J Nephrol. 2012;2012:363901. doi: 10.1155/2012/363901. Epub 2012 Aug 29.

Background. Although uremic pruritus is a common and upsetting problem of chronic kidney disease, there is no approved treatment for it. This study was undertaken to find the efficiency of sertraline as a possible treatment for uremic pruritus. Methods....

Cite
Shakiba M, Sanadgol H, Azmoude HR, et al. Effect of sertraline on uremic pruritus improvement in ESRD patients. Int J Nephrol. 2012;2012:363901doi: 10.1155/2012/363901.
Shakiba, M., Sanadgol, H., Azmoude, H. R., Mashhadi, M. A., & Sharifi, H. (2012). Effect of sertraline on uremic pruritus improvement in ESRD patients. International journal of nephrology, 2012363901. https://doi.org/10.1155/2012/363901
Shakiba, Mansor, et al. "Effect of sertraline on uremic pruritus improvement in ESRD patients." International journal of nephrology vol. 2012 (2012): 363901. doi: https://doi.org/10.1155/2012/363901
Shakiba M, Sanadgol H, Azmoude HR, Mashhadi MA, Sharifi H. Effect of sertraline on uremic pruritus improvement in ESRD patients. Int J Nephrol. 2012;2012:363901. doi: 10.1155/2012/363901. Epub 2012 Aug 29. PMID: 22973512; PMCID: PMC3437632.
Copy Download .nbib Format: NLM
Capability of Cartilage Extract to In Vitro Differentiation of Rat Mesenchymal Stem Cells (MSCs) to Chondrocyte Lineage.

International journal of molecular and cellular medicine

Talakoob S, Joghataei MT, Parivar K, Bananej M, Sanadgol N.
PMID: 25815278
Int J Mol Cell Med. 2015;4(1):9-21.

The importance of mesenchymal stem cells (MSCs), as adult stem cells (ASCs) able to divide into a variety of different cells is of utmost importance for stem cell researches. In this study, the ability of cartilage extract to induce...

Cite
Talakoob S, Joghataei MT, Parivar K, et al. Capability of Cartilage Extract to In Vitro Differentiation of Rat Mesenchymal Stem Cells (MSCs) to Chondrocyte Lineage. Int J Mol Cell Med. 2015;4(1):9-21
Talakoob, S., Joghataei, M. T., Parivar, K., Bananej, M., & Sanadgol, N. (2015). Capability of Cartilage Extract to In Vitro Differentiation of Rat Mesenchymal Stem Cells (MSCs) to Chondrocyte Lineage. International journal of molecular and cellular medicine, 4(1), 9-21.
Talakoob, Setareh, et al. "Capability of Cartilage Extract to In Vitro Differentiation of Rat Mesenchymal Stem Cells (MSCs) to Chondrocyte Lineage." International journal of molecular and cellular medicine vol. 4,1 (2015): 9-21.
Talakoob S, Joghataei MT, Parivar K, Bananej M, Sanadgol N. Capability of Cartilage Extract to In Vitro Differentiation of Rat Mesenchymal Stem Cells (MSCs) to Chondrocyte Lineage. Int J Mol Cell Med. 2015;4(1):9-21. PMID: 25815278; PMCID: PMC4359701.
Copy Download .nbib Format: NLM
Levamisole usage as an adjuvant to hepatitis B vaccine in hemodialysis patients, yes or no?.

Nephro-urology monthly

Sanadgol H.
PMID: 23577329
Nephrourol Mon. 2013;5(1):673-8. doi: 10.5812/numonthly.3985. Epub 2012 Dec 15.

BACKGROUND: Hepatitis B virus (HBV) infection is much more common in hemodialysis patients than the general population. These patients have an impaired immune response to HBV vaccination; to that end there are certain studies that have evaluated levamisole as...

Cite
Sanadgol H. Levamisole usage as an adjuvant to hepatitis B vaccine in hemodialysis patients, yes or no?. Nephrourol Mon. 2012;5(1):673-8doi: 10.5812/numonthly.3985.
Sanadgol, H. (2013). Levamisole usage as an adjuvant to hepatitis B vaccine in hemodialysis patients, yes or no?. Nephro-urology monthly, 5(1), 673-8. https://doi.org/10.5812/numonthly.3985
Sanadgol, Houshang. "Levamisole usage as an adjuvant to hepatitis B vaccine in hemodialysis patients, yes or no?." Nephro-urology monthly vol. 5,1 (2013): 673-8. doi: https://doi.org/10.5812/numonthly.3985
Sanadgol H. Levamisole usage as an adjuvant to hepatitis B vaccine in hemodialysis patients, yes or no?. Nephrourol Mon. 2013;5(1):673-8. doi: 10.5812/numonthly.3985. Epub 2012 Dec 15. PMID: 23577329; PMCID: PMC3614321.
Copy Download .nbib Format: NLM
Engagement of non-governmental organisations in moving towards universal health coverage: a scoping review.

Globalization and health

Sanadgol A, Doshmangir L, Majdzadeh R, Gordeev VS.
PMID: 34784948
Global Health. 2021 Nov 16;17(1):129. doi: 10.1186/s12992-021-00778-1.

BACKGROUND: Developing essential health services through non-governmental organisations (NGOs) is an important strategy for progressing towards Universal Health Coverage (UHC), especially in low- and middle-income countries. It is crucial to understand NGOs' role in reaching UHC and the best...

Cite
Sanadgol A, Doshmangir L, Majdzadeh R, et al. Engagement of non-governmental organisations in moving towards universal health coverage: a scoping review. Global Health. 2021;17(1):129doi: 10.1186/s12992-021-00778-1.
Sanadgol, A., Doshmangir, L., Majdzadeh, R., & Gordeev, V. S. (2021). Engagement of non-governmental organisations in moving towards universal health coverage: a scoping review. Globalization and health, 17(1), 129. https://doi.org/10.1186/s12992-021-00778-1
Sanadgol, Arman, et al. "Engagement of non-governmental organisations in moving towards universal health coverage: a scoping review." Globalization and health vol. 17,1 (2021): 129. doi: https://doi.org/10.1186/s12992-021-00778-1
Sanadgol A, Doshmangir L, Majdzadeh R, Gordeev VS. Engagement of non-governmental organisations in moving towards universal health coverage: a scoping review. Global Health. 2021 Nov 16;17(1):129. doi: 10.1186/s12992-021-00778-1. PMID: 34784948; PMCID: PMC8594189.
Copy Download .nbib Format: NLM
Kidney diseases and COVID-19 infection: causes and effect, supportive therapeutics and nutritional perspectives.

Heliyon

Askari H, Sanadgol N, Azarnezhad A, Tajbakhsh A, Rafiei H, Safarpour AR, Gheibihayat SM, Raeis-Abdollahi E, Savardashtaki A, Ghanbariasad A, Omidifar N.
PMID: 33495739
Heliyon. 2021 Jan;7(1):e06008. doi: 10.1016/j.heliyon.2021.e06008. Epub 2021 Jan 20.

Recently, the novel coronavirus disease 2019 (COVID-19), has attracted the attention of scientists where it has a high mortality rate among older adults and individuals suffering from chronic diseases, such as chronic kidney diseases (CKD). It is important to...

Cite
Askari H, Sanadgol N, Azarnezhad A, et al. Kidney diseases and COVID-19 infection: causes and effect, supportive therapeutics and nutritional perspectives. Heliyon. 2021;7(1):e06008doi: 10.1016/j.heliyon.2021.e06008.
Askari, H., Sanadgol, N., Azarnezhad, A., Tajbakhsh, A., Rafiei, H., Safarpour, A. R., Gheibihayat, S. M., Raeis-Abdollahi, E., Savardashtaki, A., Ghanbariasad, A., & Omidifar, N. (2021). Kidney diseases and COVID-19 infection: causes and effect, supportive therapeutics and nutritional perspectives. Heliyon, 7(1), e06008. https://doi.org/10.1016/j.heliyon.2021.e06008
Askari, Hassan, et al. "Kidney diseases and COVID-19 infection: causes and effect, supportive therapeutics and nutritional perspectives." Heliyon vol. 7,1 (2021): e06008. doi: https://doi.org/10.1016/j.heliyon.2021.e06008
Askari H, Sanadgol N, Azarnezhad A, Tajbakhsh A, Rafiei H, Safarpour AR, Gheibihayat SM, Raeis-Abdollahi E, Savardashtaki A, Ghanbariasad A, Omidifar N. Kidney diseases and COVID-19 infection: causes and effect, supportive therapeutics and nutritional perspectives. Heliyon. 2021 Jan;7(1):e06008. doi: 10.1016/j.heliyon.2021.e06008. Epub 2021 Jan 20. PMID: 33495739; PMCID: PMC7817396.
Copy Download .nbib Format: NLM
Construction of a lncRNA-miRNA-mRNA network to determine the key regulators of the Th1/Th2 imbalance in multiple sclerosis.

Epigenomics

Azari H, Karimi E, Shekari M, Tahmasebi A, Nikpoor AR, Negahi AA, Sanadgol N, Mousavi P.
PMID: 34726075
Epigenomics. 2021 Nov;13(22):1797-1815. doi: 10.2217/epi-2021-0296. Epub 2021 Nov 02.

No abstract available.

Cite
Azari H, Karimi E, Shekari M, et al. Construction of a lncRNA-miRNA-mRNA network to determine the key regulators of the Th1/Th2 imbalance in multiple sclerosis. Epigenomics. 2021;13(22):1797-1815doi: 10.2217/epi-2021-0296.
Azari, H., Karimi, E., Shekari, M., Tahmasebi, A., Nikpoor, A. R., Negahi, A. A., Sanadgol, N., & Mousavi, P. (2021). Construction of a lncRNA-miRNA-mRNA network to determine the key regulators of the Th1/Th2 imbalance in multiple sclerosis. Epigenomics, 13(22), 1797-1815. https://doi.org/10.2217/epi-2021-0296
Azari, Hanieh, et al. "Construction of a lncRNA-miRNA-mRNA network to determine the key regulators of the Th1/Th2 imbalance in multiple sclerosis." Epigenomics vol. 13,22 (2021): 1797-1815. doi: https://doi.org/10.2217/epi-2021-0296
Azari H, Karimi E, Shekari M, Tahmasebi A, Nikpoor AR, Negahi AA, Sanadgol N, Mousavi P. Construction of a lncRNA-miRNA-mRNA network to determine the key regulators of the Th1/Th2 imbalance in multiple sclerosis. Epigenomics. 2021 Nov;13(22):1797-1815. doi: 10.2217/epi-2021-0296. Epub 2021 Nov 02. PMID: 34726075.
Copy Download .nbib Format: NLM
An Updated Review of Various Medicinal Applications of p-Co umaric Acid: From Antioxidative and Anti-Inflammatory Properties to Effects on Cell Cycle and Proliferation.

Mini reviews in medicinal chemistry

Abazari MF, Nasiri N, Karizi SZ, Nejati F, Haghi-Aminjan H, Norouzi S, Piri P, Estakhr L, Faradonbeh DR, Kohandani M, Daliri K, Sanadgol N, Askari H.
PMID: 33459233
Mini Rev Med Chem. 2021;21(15):2187-2201. doi: 10.2174/1389557521666210114163024.

P-Coumaric acid (p-CA) is a hydroxycinnamic acid, an organic compound that is a hydroxyl derivative of cinnamic acid. P-CA is the most abundant isomer in nature and can be found in a wide variety of edible plants such as...

Cite
Abazari MF, Nasiri N, Karizi SZ, et al. An Updated Review of Various Medicinal Applications of p-Co umaric Acid: From Antioxidative and Anti-Inflammatory Properties to Effects on Cell Cycle and Proliferation. Mini Rev Med Chem. 2021;21(15):2187-2201doi: 10.2174/1389557521666210114163024.
Abazari, M. F., Nasiri, N., Karizi, S. Z., Nejati, F., Haghi-Aminjan, H., Norouzi, S., Piri, P., Estakhr, L., Faradonbeh, D. R., Kohandani, M., Daliri, K., Sanadgol, N., & Askari, H. (2021). An Updated Review of Various Medicinal Applications of p-Co umaric Acid: From Antioxidative and Anti-Inflammatory Properties to Effects on Cell Cycle and Proliferation. Mini reviews in medicinal chemistry, 21(15), 2187-2201. https://doi.org/10.2174/1389557521666210114163024
Abazari, Mohammad Foad, et al. "An Updated Review of Various Medicinal Applications of p-Co umaric Acid: From Antioxidative and Anti-Inflammatory Properties to Effects on Cell Cycle and Proliferation." Mini reviews in medicinal chemistry vol. 21,15 (2021): 2187-2201. doi: https://doi.org/10.2174/1389557521666210114163024
Abazari MF, Nasiri N, Karizi SZ, Nejati F, Haghi-Aminjan H, Norouzi S, Piri P, Estakhr L, Faradonbeh DR, Kohandani M, Daliri K, Sanadgol N, Askari H. An Updated Review of Various Medicinal Applications of p-Co umaric Acid: From Antioxidative and Anti-Inflammatory Properties to Effects on Cell Cycle and Proliferation. Mini Rev Med Chem. 2021;21(15):2187-2201. doi: 10.2174/1389557521666210114163024. PMID: 33459233.
Copy Download .nbib Format: NLM
Clinical and Epidemiological Characteristics of Postdischarge Patients With COVID-19 in Tehran, Iran: Protocol for a Prospective Cohort Study (Tele-COVID-19 Study).

JMIR research protocols

Jalilian Khave L, Vahidi M, Shirini D, Sanadgol G, Ashrafi F, Arab-Ahmadi M, Fatemi A, Shabani Barzegar M, Hassanzadeh T, Rezaei B, Zali A, Ommi D, Nohesara S, Jalili Khoshnood R, Abdi S, Pirsalehi A, Masarat E, Shokoohi M, Karamouzian M.
PMID: 33471777
JMIR Res Protoc. 2021 Feb 02;10(2):e23316. doi: 10.2196/23316.

BACKGROUND: COVID-19 was declared a pandemic on March 11, 2020. Given that the severe shortage of hospital beds has led to early discharge and insufficient patient education on home care routines and isolation protocols, the close follow-up of patients...

Cite
Jalilian Khave L, Vahidi M, Shirini D, et al. Clinical and Epidemiological Characteristics of Postdischarge Patients With COVID-19 in Tehran, Iran: Protocol for a Prospective Cohort Study (Tele-COVID-19 Study). JMIR Res Protoc. 2021;10(2):e23316doi: 10.2196/23316.
Jalilian Khave, L., Vahidi, M., Shirini, D., Sanadgol, G., Ashrafi, F., Arab-Ahmadi, M., Fatemi, A., Shabani Barzegar, M., Hassanzadeh, T., Rezaei, B., Zali, A., Ommi, D., Nohesara, S., Jalili Khoshnood, R., Abdi, S., Pirsalehi, A., Masarat, E., Shokoohi, M., & Karamouzian, M. (2021). Clinical and Epidemiological Characteristics of Postdischarge Patients With COVID-19 in Tehran, Iran: Protocol for a Prospective Cohort Study (Tele-COVID-19 Study). JMIR research protocols, 10(2), e23316. https://doi.org/10.2196/23316
Jalilian Khave, Laya, et al. "Clinical and Epidemiological Characteristics of Postdischarge Patients With COVID-19 in Tehran, Iran: Protocol for a Prospective Cohort Study (Tele-COVID-19 Study)." JMIR research protocols vol. 10,2 (2021): e23316. doi: https://doi.org/10.2196/23316
Jalilian Khave L, Vahidi M, Shirini D, Sanadgol G, Ashrafi F, Arab-Ahmadi M, Fatemi A, Shabani Barzegar M, Hassanzadeh T, Rezaei B, Zali A, Ommi D, Nohesara S, Jalili Khoshnood R, Abdi S, Pirsalehi A, Masarat E, Shokoohi M, Karamouzian M. Clinical and Epidemiological Characteristics of Postdischarge Patients With COVID-19 in Tehran, Iran: Protocol for a Prospective Cohort Study (Tele-COVID-19 Study). JMIR Res Protoc. 2021 Feb 02;10(2):e23316. doi: 10.2196/23316. PMID: 33471777; PMCID: PMC7857388.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 25 entries